https://www.selleckchem.com/pr....oducts/alpha-conotox
These studies utilized a prospective cohort design with an average sample size of 531. CONCLUSION The majority of literature describing the use of ML in clinical medicine is retrospective in nature and often outlines proof-of-concept approaches to impact patient care. We postulate that identifying and overcoming key translational barriers, including real-time access to clinical data, data security, physician approval of "black box" generated results, and performance evaluation will allow for a fundamental shift in medical pra
Like
Comment
Share
